Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
PPHM > SEC Filings for PPHM > Form 8-K on 13-Feb-2013All Recent SEC Filings

Show all filings for PEREGRINE PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for PEREGRINE PHARMACEUTICALS INC

13-Feb-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On February 13, 2013, Peregrine Pharmaceuticals, Inc. issued a press release announcing results from its 70 patient open-label, randomized Phase II clinical trial of bavituximab used in combination with gemcitabine in patients with previously untreated, advanced Stage IV pancreatic cancer.

A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:

Exhibit

Number

99.1 Press Release issued February 13, 2013.

  Add PPHM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PPHM - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.